(Q46081477)

19 December 2017

title

Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer's disease: the ALZHEMED (Tramiprosate) experience (English)

1 reference

19 December 2017

0 references

1 reference

5

1 reference

19 December 2017

author name string

D Saumier

1

1 reference

19 December 2017

P S Aisen

2

1 reference

19 December 2017

S Gauthier

3

1 reference

19 December 2017

B Vellas

4

1 reference

19 December 2017

A Duong

6

1 reference

19 December 2017

J Suhy

7

1 reference

19 December 2017

J Oh

8

1 reference

19 December 2017

W Lau

9

1 reference

19 December 2017

D Garceau

10

1 reference

19 December 2017

D Haine

11

1 reference

19 December 2017

J Sampalis

12

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

The Journal of Nutrition, Health and Aging

published in

1 reference

19 December 2017

volume

13

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

370-372

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s12603-009-0047-4

exact match

0 references

cites work

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0047-4

Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0047-4

Higher atrophy rate of entorhinal cortex than hippocampus in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0047-4

Hippocampal atrophy in persons with age-associated memory impairment: volumetry within a common space

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0047-4

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-009-0047-4

Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress

21 January 2018

1 reference

12 December 2020

Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia

1 reference

12 December 2020

Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions

1 reference

12 December 2020

The role of biomarkers in clinical trials for Alzheimer disease

1 reference

12 December 2020

Biomarkers and surrogate markers: an FDA perspective

1 reference

12 December 2020

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

1 reference

12 December 2020

Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation.

1 reference

12 December 2020

A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.

1 reference

12 December 2020

A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age.

1 reference

12 December 2020

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

12 December 2020

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.

1 reference

12 December 2020

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

Alzheimer disease: disease modifying trials; where are we? Where do we need to go? A reflective paper.

1 reference

12 December 2020

Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis.

1 reference

12 December 2020

The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease

1 reference

12 December 2020

Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12603-009-0047-4

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017